SAPS II Score Calculator

SAPS II Score Calculator for Critical Care. Higher scores map monotonically to higher predicted mortality: roughly, a SAPS II near 30 corresponds to about 10-15% predicted mortality, near 50 to roughly 45-55%, and above 70 to greater than 80%. The clinically actionable output is not the raw points but the derived mortality probability, which is used to stratify severity and, aggregated across a cohort, to compute a standardized mortality ratio; an SMR above 1.0 signals more deaths than the model predicts. Because the original coefficients were calibrated in 1993, absolute predictions frequently overestimate contemporary mortality, so many units recalibrate or apply updated versions such as SAPS II expanded or SAPS 3.

How this calculator works

SAPS II sums points from 17 items scored on the worst value recorded during the first 24 hours of ICU admission: 12 physiologic variables (heart rate, systolic blood pressure, temperature, Glasgow Coma Scale, PaO2/FiO2 ratio while ventilated or on CPAP, urine output, serum urea or BUN, WBC, serum potassium, sodium, bicarbonate, and bilirubin), age, admission type (scheduled surgical, medical, or unscheduled surgical), and three comorbidities (AIDS, metastatic cancer, hematologic malignancy). The raw score ranges from 0 to 163 and is converted to a predicted hospital mortality by logistic regression: logit = -7.7631 + 0.0737 x (SAPS II) + 0.9971 x ln(SAPS II + 1), with mortality = e^logit / (1 + e^logit).

When to use this calculator

Use SAPS II for adult ICU patients to estimate hospital mortality risk and to benchmark ICU performance via standardized mortality ratios (observed/expected deaths), not to guide individual treatment decisions. It was designed to work without a primary diagnosis, so it suits mixed medical-surgical units. It was derived excluding patients under 18 years, burn patients, coronary care unit patients, and cardiac surgery patients, and should not be applied to those groups or used as a standalone triage or withdrawal-of-care tool.

Inputs used

  • Age
  • Admission type
  • Vital signs
  • Urine output
  • Laboratory values
  • Glasgow Coma Scale
  • Chronic disease variables

Clinical interpretation

Higher scores map monotonically to higher predicted mortality: roughly, a SAPS II near 30 corresponds to about 10-15% predicted mortality, near 50 to roughly 45-55%, and above 70 to greater than 80%. The clinically actionable output is not the raw points but the derived mortality probability, which is used to stratify severity and, aggregated across a cohort, to compute a standardized mortality ratio; an SMR above 1.0 signals more deaths than the model predicts. Because the original coefficients were calibrated in 1993, absolute predictions frequently overestimate contemporary mortality, so many units recalibrate or apply updated versions such as SAPS II expanded or SAPS 3.

Worked example

A 70-year-old medical admission (age 60-69 contributes points, and medical admission type adds points) with a Glasgow Coma Scale of 8, systolic BP of 85 mmHg, heart rate of 130, and moderately deranged bicarbonate and urea might accumulate a SAPS II near 52. Plugging 52 into the equation: logit = -7.7631 + 0.0737 x 52 + 0.9971 x ln(53) = -7.7631 + 3.832 + 3.960 = 0.029, giving a predicted hospital mortality of about 51%.

Limitations and safety notes

SAPS II discrimination remains reasonable (original AUC 0.86 in validation) but its calibration has drifted over three decades, so it systematically overpredicts death in many current cohorts and requires local recalibration for fair benchmarking. It excludes cardiac surgery, burns, coronary, and pediatric patients, performs poorly in these and in single-diagnosis populations, and is sensitive to lead-time bias and to how aggressively worst values are captured in the first 24 hours. It is a population-level prognostic instrument and must never be used to predict an individual patient's outcome or to justify limiting care.

Frequently asked questions

How is SAPS II different from APACHE II?

Both estimate ICU mortality from first-24-hour physiology, but SAPS II uses only 17 variables and deliberately avoids requiring a primary admission diagnosis, whereas APACHE II incorporates a chronic health evaluation and a diagnosis-weighted coefficient. SAPS II is often simpler to compute across mixed medical-surgical cohorts.

Why does SAPS II sometimes overpredict deaths?

The mortality equation was calibrated on 1990s data. ICU care has improved since, so applying the original coefficients typically inflates expected mortality. Units benchmarking performance should recalibrate the model locally or use SAPS 3 or the expanded SAPS II.

What is the point range and when are values collected?

The raw score runs from 0 to 163. Each of the 17 items is scored using the worst (most abnormal) value observed during the first 24 hours after ICU admission; the totals are then summed and converted to a mortality probability.

Can SAPS II be used to decide on withdrawing care for a patient?

No. It is validated only for group-level mortality estimation and quality benchmarking. Individual-level predictions carry wide uncertainty, so the score must not drive triage, withdrawal, or resource-rationing decisions for a single patient.

Which patients are excluded from SAPS II?

The derivation cohort excluded patients under 18 years, burn patients, coronary care unit patients, and cardiac surgery patients, so the model is not validated for these populations.

References

  • Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993. PMID: 8254858.
  • Moreno RP, Metnitz PG, Almeida E, et al. SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005. PMID: 16132892.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: June 22, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators